Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications clinical unmet needs burden fragile x syndrome results targeted literature review
… market research panels, but there was a wide range of results across the studies. Based on these results, we recommend a variety of approaches for analyzing …
… Integrated Real-World Clinical and Economic Evaluation of Treatment Alternatives … real-world effectiveness data to compare the long-term clinical and economic value of various DMTs for MS. CHALLENGE … registries—are not typically designed to meet the needs of economic evaluations used by payers and …
… & Immunisation Conference 2023. Economic and HRQoL burden in adults with RSV: a systematic literature review. Panozzo CA, Grace M, Costello J, Colosia A, Wolowacz …
… However, often, the knowledge needed to make good clinical, market access, and safety decisions isn’t readily … Solutions can partner with you to gather evidence, analyze results, and disseminate your research . We'll help you …
… for each target market or country. With access to clinical trial data, outcomes data, and published economic …
… as well as facilitating the interpretation of results in terms of responder definitions and minimal … and EMA submissions or guide decision making in routine clinical care. Our psychometric services include: … Rasch Measurement Theory Psychometric evaluations based on clinical trial or observational study data Cross-sectional …
… Are Companies Responding to Expected Challenges with Joint Clinical Assessments? Share on: September 10, 2024 Image … for the JCA dossier, including epidemiology, systematic literature review (SLR), and indirect treatment comparisons, these …
Dr. Garcia de Albeniz Speaking at NASEM About Target Trial Emulation to Evaluate Drugs for Rare Diseases Share on: Tuesday, February 6 - Wednesday, February 7, 2024 Meeting website In response to a US Congressional request, an ad hoc committee of the …
… associated with a significant humanistic and economic burden. While there is no cure for MS, disease-modifying … data from the international MSBase registry we studied the clinical effectiveness of switching to natalizumab for … to established first-line therapies. We combined these results with survey data on the burden of MS in European …
… in the Inclusion of Patient Reported Outcomes in Oncology Clinical Trials Margaret Mordin, MS Vice President, Market … in the inclusion of patient reported outcomes in oncology clinical trials: analysis of clinicaltrials.gov (2013-2022) … A Transcript An article published in 2015 from a review of clinicaltrials.gov indicated that between 2007 and …